Skip to main content

Advertisement

Log in

Is the incidence of invasive vulvar cancer increasing in the United States?

  • Brief report
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective

To document incidence rates of vulvar cancer, specifically invasive vulvar cancer, from 1973 to 2004 in the United States.

Methods

Nine US cancer registries from the Surveillance, Epidemiology, and End Results (SEER) databases were used to identify women aged 15–84 years, who were first diagnosed with vulvar cancer during 1973–2004. Age-adjusted incidence rates and annual percentage changes were calculated for different time periods, stage of the disease, age, race, and geographic area.

Results

During 1973–2004, the incidence of in situ vulvar tumors increased by an average of 3.5% per year (95% CI: 2.9%, 4.1%), while the incidence of invasive tumors increased 1.0% per year (95% CI: 0.6%, 1.4%). An increasing incidence was observed for localized and regional invasive tumors. To at least some degree, the rise of incidence rates of incidence tumors was evident in every age category, race, and geographic region.

Conclusions

Incidence rates of invasive vulvar cancer have increased in the United States during the last three decades. The reasons for this increase are unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107:1018–1022

    PubMed  Google Scholar 

  2. Surveillance, Epidemiology, and End Results (SEER) program (www.seer.cancer.gov), SEER*Stat Database: incidence—SEER 9 Regs limited-use, Nov. 2006 Sub (1973–2004) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission

  3. Madeleine MM, Daling JR (2006) Cancers of the vulva and vagina. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 1068–1074

    Google Scholar 

  4. Carter JJ, Madeleine MM, Shera K et al (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61:1934–1940

    CAS  PubMed  Google Scholar 

  5. Saraiya M, Watson M, Wu X et al (2008) Incidence of in situ and invasive vulvar cancer in the US, 1998–2003. Cancer 113:2865–2872

    Article  PubMed  Google Scholar 

  6. Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813–819

    Article  CAS  PubMed  Google Scholar 

  7. Chiasson MA, Ellerbrock TV, Bush TJ, Sun XW, Wright TCJ (1997) Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 89:690–694

    Article  CAS  PubMed  Google Scholar 

  8. Elit L, Voruganti S, Simunovic M (2005) Invasive vulvar cancer in a woman with human immunodeficiency virus: case report and review of the literature. Gynecol Oncol 98:151–154

    Article  CAS  PubMed  Google Scholar 

  9. Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500–1510

    Article  CAS  PubMed  Google Scholar 

  10. Bhaskaran K, Hamouda O, Sannes M et al (2008) Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 300:51–59

    Article  CAS  PubMed  Google Scholar 

  11. Port FK, Merion RM, Roys EC, Wolfe RA (2008) Trends in organ donation and transplantation in the United States, 1997–2006. Am J Transplant 8:911–921

    Article  CAS  PubMed  Google Scholar 

  12. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59–67

    Article  PubMed  Google Scholar 

  13. Daling JR, Sherman KJ, Hislop TG et al (1992) Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135:180–189

    CAS  PubMed  Google Scholar 

  14. Madeleine MM, Daling JR, Carter JJ et al (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89:1516–1523

    Article  CAS  PubMed  Google Scholar 

  15. CDC (2007) Cigarette smoking among adults—United States, 2006. MMWR 57:1157–1161

    Google Scholar 

Download references

Acknowledgments

Financial support: Dr. Bodelon was funded by the Cancer Epidemiology Biostatistics Training Grant T32 CA009168.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clara Bodelon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bodelon, C., Madeleine, M.M., Voigt, L.F. et al. Is the incidence of invasive vulvar cancer increasing in the United States?. Cancer Causes Control 20, 1779–1782 (2009). https://doi.org/10.1007/s10552-009-9418-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-009-9418-8

Keywords

Navigation